9/20/2004

Pfizer is continuing to lobby China's State Intellectual Property Office to get back its patent for Viagra. The company is asking the department to reconsider its decision overturning the Viagra patent and faces an Oct. 5 deadline for appealing the decision. A company official said Pfizer is "hopeful and cautiously optimistic" the Chinese agency will allow the decision to be appealed.

Related Summaries